TransMedics Group (TMDX) Q3 Revenue Beat; Raises FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
TransMedics Group (TMDX) surges 30% on strong revenue beat and guidance
November 6, 2023 4:21 PM ESTTransMedics Group (NASDAQ: TMDX) surges after strong Q3 revenue beat and raised FY revenue guidance:
reported Q3 EPS of ($0.78), $0.62 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $66.4 million versus the consensus estimate of $49.19 million.sees FY 2023... More